← Back to Search

Behavioural Intervention

Short Walks to Break Up Sitting for Type 2 Diabetes

N/A
Recruiting
Led By Mary O Whipple, PhD, RN, PHN
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 2 diabetes (hemoglobin A1c ≥6.5% and/or previous diagnosis of type 2 diabetes)
Postmenopausal (females only, ≥12 months without a menstrual period)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will compare the effects of prolonged sitting vs. breaking it up with short walks on markers of heart health in both men & women.

Who is the study for?
This trial is for people over 60 with Type 2 diabetes who are mostly inactive, sitting for more than 6 hours a day. It's not for those on dialysis, with a history of DVT, unstable conditions, recent hormone therapy changes, meeting exercise guidelines, physical disabilities affecting movement, Type 1 diabetes or uncontrolled high blood pressure.Check my eligibility
What is being tested?
The study tests how breaking up sitting time affects heart health in older adults with Type 2 diabetes. Participants will try three different routines: just sitting for four hours; walking five minutes every hour; and one longer walk of twenty minutes during the four hours.See study design
What are the potential side effects?
Since this trial involves basic activities like walking at your own pace and periods of rest without any medication involved, side effects are minimal but could include typical exercise-related issues such as muscle soreness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have type 2 diabetes with an A1c of 6.5% or higher.
Select...
I am a woman and have not had a period for at least 12 months.
Select...
I am 60 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
iAUC of SBP
Secondary outcome measures
Net iAUC of DBP
Net iAUC of HR
Net iAUC of of MAP

Trial Design

3Treatment groups
Experimental Treatment
Group I: CONExperimental Treatment1 Intervention
Control group
Group II: BreakExperimental Treatment1 Intervention
Group III: BOUTExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,695 Total Patients Enrolled
Mary O Whipple, PhD, RN, PHNPrincipal InvestigatorUniversity of Minnesota
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

prolonged SB (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05838586 — N/A
Cardiovascular Disease Research Study Groups: CON, Break, BOUT
Cardiovascular Disease Clinical Trial 2023: prolonged SB Highlights & Side Effects. Trial Name: NCT05838586 — N/A
prolonged SB (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838586 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to enroll in the study currently?

"As per records on clinicaltrials.gov, the recruitment for this medical trial has been suspended since April 28th 2023. The study was posted to the website on May 1st of that same year. Despite its inactivity, there are over 1800 other trials actively recruiting at present."

Answered by AI

Who else is applying?

What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Other medications haven't worked; hopefully these will.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes
2023. "Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05838586.
~53 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top